VitaSpring Biomedical Co (VSBC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 2 sessions, February 12, 2026 to October 8, 2026
Company Description
VitaSpring Biomedical Co (OTC: VSBC) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $6.6M.
For FY2026, VitaSpring Biomedical Co reported revenue of $0 and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for VSBC, including price data, SEC filings, and financial highlights.
Stock Performance
VitaSpring Biomedical Co (VSBC) closed at $0.0318 on October 8, 2026.
VSBC Metrics & Rankings
Price returns through October 8, 2026. Ranking links may use different dates.
Latest News
SEC Filings
VitaSpring Biomedical Co has filed 8 recent SEC filings, including 4 Form 10-Q, 2 Form 10-K, 1 Form NT 10-Q, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VSBC SEC filings →
Financial Highlights
Upcoming Events
VSBC Company Profile & Sector Positioning
VitaSpring Biomedical Co (VSBC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing VSBC often look at related companies in the same sector, including EOM Pharmaceutical Hldngs (IMUC), TRON Group Inc (TGRP), Oncotelic Therapeutcs Inc (OTLC), COSCIENS Biopharma Inc (CSCIF), and OSR Health Inc (OSRH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VSBC's relative position within its industry.